Serum osteopontin levels - Is it time to screen asbestos-exposed workers for pleural mesothelioma?

New England Journal of Medicine

Volumn 353, Issue 15, 2005, Pages 1617-1618

  Cullen, Mark R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; OSTEOPONTIN;

ASBESTOSIS; CANCER RISK; DIFFERENTIAL DIAGNOSIS; EDITORIAL; HUMAN; LUNG BIOPSY; LUNG CARCINOGENESIS; LUNG CARCINOMA; OCCUPATIONAL EXPOSURE; PATIENT MONITORING; PLEURA MESOTHELIOMA; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCREENING TEST;

ASBESTOS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MESOTHELIOMA; OCCUPATIONAL EXPOSURE; OSTEOPONTIN; PLEURAL NEOPLASMS; SIALOGLYCOPROTEINS;

EID: 26444521661     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe058176     Document Type: Editorial

References (9)

1. Pass HI, Lott D, Lonardo F, et al. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med 2005;353:1564-73.
2. Weill H, Hughes JM, Churg AM. Changing trends in US mesothelioma incidence. Occup Environ Med 2004;61:438-41.
3. Steele JP. Prognostic factors in mesothelioma. Semin Oncol 2002;29:36-40.
4. Ceresoli GL, Locati LD, Ferreri AJ, et al. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer 2001;34:279-87.
5. Hughes RS. Malignant pleural mesothelioma. Am J Med Sci 2005;329:29-44.
6. Marukawa M, Hiyama J, Shiota Y, et al. The usefulness of CYFRA 21-1 in diagnosing and monitoring malignant pleural mesothelioma. Acta Med Okayama 1998;52:119-23.
7. Robinson BW, Creaney J, Lake R. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 2003;362:1612-6.
8. Cullen MR. Chrysotile asbestos: enough is enough. Lancet 1998;351:1377-8. [Erratum, Lancet 1998;351:1742.]
9. Rusch VW, Rosenzweig K, Venkatraman E, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;122:788-95.